Welcome to our weekly update on Dromadis Health! 👋
As usual, comments and feedback are suuuuper welcome. Email us, comment on this post, or just reach out for a chat, we’re friendly people! 😁
Quick refresher
We’re building Asparagus, a device that analyses your urine directly from your toilet bowl. You can choose how often, for how long, and what you want to track from the list below:
diet 🥗
hydration 💧
hormones ⭐
fat burn 🏃♂️
early markers of chronic diseases (e.g. pre-diabetes, kidney disease), to catch them while they’re reversible 💪
We’re helping you take control of your health and get in sync with your body.
This week, in short
We worked on the first 3D design of Asparagus, learned more about our first customers, and prepared ourselves for a month-long lockdown! 😷
Week #6 accomplishments
🧊 We worked on the first 3D design of Asparagus
Last week, we showed you the first rough sketches of Asparagus. This week, we literally took it to the next dimension.
Why do this now? Getting a 3D design allows us to better understand the different technical challenges around the collection system and de-risk our technology. We also now have something we can show people. This will be key for our digital advertising experiments.
Thank you to the amazing Pete Foxworthy for turning our drawings into these stunning mockups. 🙌
Would YOU put such a device in YOUR toilet? Do you have any ideas on how to improve it? Vote below to let us know 👇
💬 We collected feedback on the first iteration of the design
A recurrent point was that those who pee sitting down think they will have a hard time aiming on the device. We’re exploring different ways to make the experience as effortless as possible, such as being able to easily move the device to the front, or modify the internal collection system.
Thanks to all of you who gave us design feedback from last week, it has been super helpful! 🤗
☀️ We enjoyed the last day before lockdown
Lockdown 2.0 started yesterday in the UK, we knew we won’t be seeing each other for at least a month. So we HAD to get brunch together! So that’s what we did and we also enjoyed walking around sunny London Bridge.
We set up the tools we needed to stay productive while remote, so all should be fine. 👌
📚 We got to know our customers better
We started setting up audiences for our digital marketings ads this week. In order to do so, we dove deeper in specific customer segments. Building on the last weeks of work, we wanted to identify the largest groups of people who would get the most value out of Asparagus.
This week, we looked into / talked to people who are looking for a diet change and are at risk of specific diseases linked with being overweight. A few facts:
63% of adults in the UK are clinically overweight (BMI > 25). Being overweight comes with increased risks of many health complications.
50% of Brits took up a diet in the last yet, 2/3 of which are on a diet "most of the time".
1 in 3 adult in the UK is pre-diabetic. 84% of them don't know they have it. Pre-diabetes is a reversible health condition. Prediabetes puts you at increased risk of developing type 2 diabetes, heart disease, and stroke.
20 people every day in the UK develop a kidney failure. This is often a result of uncontrolled Chronic Kidney Disease (CKD). 1 in 10 UK adults have CKD. 50% of them don’t know it.
Pre-diabetes and kidney function tests can be conducted routinely through urine. This means a large chunk of this is preventible.
Only 8.1 % of UK adults between the age of 40 and 75 received an NHS health check in 2019.
🔧 We started working on our MVP
Thanks to you all, we have £150 to build the first Asparagus MVP (minimal viable product).
This week, we got started on designing the system of urine biosensors. It’s very exciting. We’ll keep you in the loop of things! 👌
I heard a rumor… 🤫
We may just have gotten access to a few thousand urine samples to test Asparagus. 🤫
More updates soon.
What’s next?
🧊 Finalize 3D mockup of Asparagus
🧪 Run ads to quantify demand
🔧 Continue building the first MVP
Thanks for reading our update, please leave a comment or question below. Feel free to share this newsletter with whoever you think will find it interesting!
See you next week 👋